Core Insights - The stock price of Yaoyigou (300937) closed at 31.19 yuan on August 1, 2025, reflecting a 2.56% increase with a turnover rate of 8.9% and a trading volume of 55,800 hands, amounting to 174 million yuan in transaction value [1] Financial Performance - For Q1 2025, the company reported total revenue of 1.138 billion yuan, a year-on-year decrease of 8.06% - The net profit attributable to shareholders was 4.1837 million yuan, down 54.65% year-on-year - The net profit after deducting non-recurring items was 3.564 million yuan, a decrease of 41.49% year-on-year - The current ratio stood at 1.622, the quick ratio at 1.110, and the debt-to-asset ratio at 51.62% [1] Company Overview - Sichuan Hezhong Yaoyigou Pharmaceutical Co., Ltd. was established in 2007 and is located in Chengdu, primarily engaged in the pharmaceutical manufacturing industry - The company has a registered capital of 956.67 million yuan and a paid-in capital of 507.8 million yuan - The legal representative of the company is Li Yanfei [1] Investment and Intellectual Property - The company has made investments in 25 enterprises and participated in 26 bidding projects - It holds 183 trademark registrations and 16 patents, along with 34 administrative licenses [2]
药易购（300937）8月1日主力资金净流入1301.10万元